PatientsVille.com Logo

PatientsVille

Sucralfate Side Effects

Common Sucralfate Side Effects


The most commonly reported Sucralfate side effects (click to view or check a box to report):

Pain (11)
Rash (8)
Nausea (8)
Liver Disorder (8)
Bezoar (7)
Diarrhoea (7)
Pyrexia (7)
Dyspnoea (7)
Pruritus (6)
Anxiety (6)
Abdominal Pain (6)
Cholelithiasis (5)
Abdominal Pain Upper (5)
Cholecystitis Chronic (5)
Gastrointestinal Haemorrhage (5)
Hepatic Function Abnormal (5)
Malaise (5)
Intra-uterine Death (5)
Scrotal Oedema (4)
Vomiting (4)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Sucralfate Side Effects Reported to FDA

The following Sucralfate reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Sucralfate on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Oropharyngeal Pain, Activities Of Daily Living Impaired
This is a report of a 83-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Sucralfate (dosage: NA, start time: NS), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Oropharyngeal Pain
  • Activities Of Daily Living Impaired
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sucralfate treatment in female patients, resulting in oropharyngeal pain side effect.

Rash Pruritic, Hypercalcaemia, Hypervitaminosis D
This report suggests a potential Sucralfate Rash Pruritic, Hypercalcaemia, Hypervitaminosis D side effect(s) that can have serious consequences. A 61-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: gastritis and used Sucralfate (dosage: 1 Four Times Daily Taken By Mouth) starting Aug 28, 2013. Soon after starting Sucralfate the patient began experiencing various side effects, including:
  • Rash Pruritic
  • Hypercalcaemia
  • Hypervitaminosis D
Drugs used concurrently: NA. Although Sucralfate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as rash pruritic, may still occur.

Choking, Dysphagia
This Choking, Dysphagia problem was reported by a consumer or non-health professional from US. A 40-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: gastrooesophageal reflux disease. On Sep 10, 2013 this consumer started treatment with Sucralfate (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Sucralfate, the patient experienced the following unwanted symptoms/side effects:
  • Choking
  • Dysphagia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as choking, may become evident only after a product is in use by the general population.

Agranulocytosis
This is a report of a 48-year-old female patient (weight: NA) from FR. The patient developed the following symptoms/conditions: NA and was treated with Sucralfate (dosage: NA) starting Jul 28, 2013. Concurrently used drugs:
  • Lasilix
  • Lopril
  • Vancomycine
Soon after that, the consumer experienced the following side effects:
  • Agranulocytosis
This opens a possibility that Sucralfate treatment could cause the above reactions, including agranulocytosis, and some female subjects may be more susceptible.


Pruritus, Arthralgia, Musculoskeletal Pain, Oropharyngeal Pain, Hypersensitivity
A 51-year-old female patient (weight: NA) from US with the following symptoms/conditions: diarrhoea,post procedural complication,cholecystectomy started Sucralfate treatment (dosage: NA) on Sep 05, 2013. Soon after starting Sucralfate treatment, the subject experienced various side effects, including:
  • Pruritus
  • Arthralgia
  • Musculoskeletal Pain
  • Oropharyngeal Pain
  • Hypersensitivity
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Sucralfate.

Back Pain, Dysstasia, Gait Disturbance
A 55-year-old female patient from US (weight: NA) experienced symptoms, such as: gastrooesophageal reflux disease,ulcer and was treated with Sucralfate(dosage: 2 Twice Daily Taken By Mouth). The treatment was initiated on NS. After that a consumer reported the following side effect(s):
  • Back Pain
  • Dysstasia
  • Gait Disturbance
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Sucralfate efficacy: NA.

Neutropenia, Enterococcal Infection, Escherichia Infection, Toxicity To Various Agents, Bone Marrow Myelogram Abnormal
In this report, Sucralfate was administered for the following condition: NA.A 61-year-old male consumer from FR (weight: NA) started Sucralfate treatment (dosage: NA) on Jun 04, 2013.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Neutropenia
  • Enterococcal Infection
  • Escherichia Infection
  • Toxicity To Various Agents
  • Bone Marrow Myelogram Abnormal
A possible interaction with other drugs could have contributed to this reaction:
  • Amoxicillin
  • Mecir
  • Ipratropium
  • Haldol
  • Aotal
  • Terbutaline
  • Ceftriaxone
  • Metronidazole
The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Sucralfate treatment could be related to the listed above side effect(s).

Choking, Foreign Body, Depressed Level Of Consciousness, Dysphagia, Fear, Anxiety, Basedow^s Disease, Malaise
This is a report of the following Sucralfate side effect(s):
  • Choking
  • Foreign Body
  • Depressed Level Of Consciousness
  • Dysphagia
  • Fear
  • Anxiety
  • Basedow^s Disease
  • Malaise
A 23-year-old female patient from US (weight: NA) presented with the following condition: abdominal pain and received a treatment with Sucralfate (dosage: NA) starting: Apr 04, 2013.The following concurrently used drugs could have generated interactions: NA.This report suggests that a Sucralfate treatment could be associated with the listed above side effect(s).

Hypophosphataemia, Disease Progression
This Sucralfate report was submitted by a 72-year-old male consumer from TH (weight: NA). The patient was diagnosed with: NA and Sucralfate was administered (dosage: NA) starting: Dec 26, 2000. The consumer developed a set of symptoms:
  • Hypophosphataemia
  • Disease Progression
Other drugs used simultaneously:
  • Ceftazidime
  • Potassium Chloride (potassium Chloride)
  • Diazepam (diazepam)
  • Fenoterol Hydrobromide W/ipratropium Bromide( Fenoterol Hydrobromide, Ipratropium Bromide)
  • Aminophylline (aminophylline)
  • Ceftriaxone (ceftriaxone)
Those unexpected symptoms could be linked to a Sucralfate treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Cholelithiasis, Cholecystitis Chronic, Biliary Dyskinesia, Abdominal Pain, Injury, Anxiety, Emotional Distress
This is a report of a possible correlation between Sucralfate use and the following symptoms/side effect(s):
  • Cholelithiasis
  • Cholecystitis Chronic
  • Biliary Dyskinesia
  • Abdominal Pain
  • Injury
  • Anxiety
  • Emotional Distress
which could contribute to an assessment of Sucralfate risk profile.A 22-year-old female consumer from US (weight: NA) was suffering from NA and was treated with Sucralfate (dosage: 1 Gm, Take One Tablet Every 6 Hours) starting 2008.Other concurrent medications:
  • Zegerid (40-1100, Take One Capsule Every Day)
  • Yaz (Unk)
  • Yasmin (Unk)
  • Ocella (Unk)
  • Promethazine (25 Mg, Take One Tablet Every 6 Hours As Needed)
  • Prevacid


Haemoglobin Decreased
A 78-year-old female patient from US (weight: NA) presented with the following symptoms: gastritis and after a treatment with Sucralfate (dosage: 1 Tab Qid Po) experienced the following side effect(s):
  • Haemoglobin Decreased
The treatment was started on NS. Sucralfate was used in combination with the following drugs: NA.This report could alert potential Sucralfate consumers.

Nausea, Malaise
In this report, a 17-year-old female patient from US (weight: NA) was affected by a possible Sucralfate, 1gm Tab, Watson Pharm side effect.The patient was diagnosed with gastric ulcer. After a treatment with Sucralfate, 1gm Tab, Watson Pharm (dosage: Let, start date: 201212), the patient experienced the following side effect(s):
  • Nausea
  • Malaise
The following simultaneously used drugs could have led to this reaction: NA.The findings here stress that side effects should be taken into consideration when evaluating a Sucralfate, 1gm Tab, Watson Pharm treatment.

Nausea, Diarrhoea, Depression
This is a report of a 16-year-old female patient from US (weight: NA), who used Sucralfate (dosage: 1 Tablet) for a treatment of gastric ulcer. After starting a treatment on Dec 31, 2012, the patient experienced the following side effect(s):
  • Nausea
  • Diarrhoea
  • Depression
The following drugs could possibly have interacted with the Sucralfate treatment NA.Taken together, these observations suggest that a Sucralfate treatment could be related to side effect(s), such as Nausea, Diarrhoea, Depression.

Abdominal Pain Upper, Diarrhoea, Nausea, Tooth Disorder
This abdominal pain upper side effect was reported by a consumer or non-health professional from US. A 64-year-old female patient (weight:NA) experienced the following symptoms/conditions: abdominal disorder,dental fillings,artificial crown insertion. The patient was prescribed Sucralfate (dosage: NA), which was started on Mar 09, 2012. Concurrently used drugs: NA. When starting to take Sucralfate the consumer reported the following symptoms:
  • Abdominal Pain Upper
  • Diarrhoea
  • Nausea
  • Tooth Disorder
These side effects may potentially be related to Sucralfate.

Dyspnoea, Wheezing, Oropharyngeal Pain, Foreign Body
This is a Sucralfate side effect report of a 67-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: oesophageal pain, who was treated with Sucralfate (dosage:NA, start time: NS), combined with: NA., and developed a serious reaction and a dyspnoea side effect. The patient presented with:
  • Dyspnoea
  • Wheezing
  • Oropharyngeal Pain
  • Foreign Body
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Sucralfate treatment in female patients suffering from oesophageal pain, resulting in dyspnoea.

Confusional State, Abnormal Behaviour, Metabolic Encephalopathy, Gastrointestinal Perforation, Diet Refusal, Axonal Neuropathy, Speech Disorder
This report suggests a potential Sucralfate confusional state side effect(s) that can have serious consequences. A 81-year-old female patient from FR (weight:NA) was diagnosed with the following health condition(s): NA and used Sucralfate (dosage: 2 G, Qd, Oral) starting Feb 24, 2012. Soon after starting Sucralfate the patient began experiencing various side effects, including:
  • Confusional State
  • Abnormal Behaviour
  • Metabolic Encephalopathy
  • Gastrointestinal Perforation
  • Diet Refusal
  • Axonal Neuropathy
  • Speech Disorder
Drugs used concurrently:
  • Levofloxacin (500 Mg, Qd, Oral)
  • Flagyl (500 Mg, Tid, Oral)
  • Mianserin Hydrochloride (10 Mg, Qd, Oral)
  • Alprazolam (0.5 Mg, Qd, Oral)
  • Sotalol Hydrochloride (160 Mg, Qd, Oral)
  • Motilium /00498201/ (domperidone)
  • Nitroglycerin
The patient was hospitalized. Although Sucralfate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as confusional state, may still occur.

Abdominal Pain Upper, Hypotension, Fatigue, Blood Pressure Decreased, Headache, Feeling Abnormal, Influenza, Dizziness
This abdominal pain upper problem was reported by a physician from UNITED STATES. A 71-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Apr 25, 2010 a consumer started treatment with Sucralfate (dosage: NA). The following drugs/medications were being taken at the same time:
  • Diovan (160 Mg Daily, Oral)
  • Bystolic
  • Nexium
  • Tramadol Hcl
When commencing Sucralfate, the patient experienced the following unwanted symptoms /side effects:
  • Abdominal Pain Upper
  • Hypotension
  • Fatigue
  • Blood Pressure Decreased
  • Headache
  • Feeling Abnormal
  • Influenza
  • Dizziness
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as abdominal pain upper, may become evident only after a product is in use by the general population.

Blood Sodium Decreased, Blood Parathyroid Hormone Increased, Hypercalcaemia, Fall, Blood Creatinine Increased, Alkalosis, Blood Albumin Decreased, Milk-alkali Syndrome, Asthenia
This is a Sucralfate side effect report of a 64-year-old male patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Sucralfate (dosage: NA) starting NS. Concurrently used drugs:
  • Calcium Carbonate (Oral)
Soon after that, the consumer experienced the following of symptoms:
  • Blood Sodium Decreased
  • Blood Parathyroid Hormone Increased
  • Hypercalcaemia
  • Fall
  • Blood Creatinine Increased
  • Alkalosis
  • Blood Albumin Decreased
  • Milk-alkali Syndrome
  • Asthenia
This opens a possibility that Sucralfate could cause blood sodium decreased and that some male patients may be more susceptible.

Chronic Graft Versus Host Disease, Pancreatitis, Gastritis, Bronchitis, Mucous Membrane Disorder, Device Occlusion, Platelet Count Decreased, Liver Disorder
A female patient (weight: NA) from JAPAN with the following symptoms: prophylaxis,myelodysplastic syndrome started Sucralfate treatment (dosage: Unk) on Mar 31, 2011. Soon after starting Sucralfate treatment, the consumer experienced several side effects, including:
  • Chronic Graft Versus Host Disease
  • Pancreatitis
  • Gastritis
  • Bronchitis
  • Mucous Membrane Disorder
  • Device Occlusion
  • Platelet Count Decreased
  • Liver Disorder
. Concurrently used drugs:
  • Fludarabine Phosphate (Unk)
  • Methylpednisolone Sodium Succinate (Unk)
  • Mixed Amino Acid Preparations For Total Parenteral Nutrition (Unk)
The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Sucralfate side effects, such as chronic graft versus host disease.

Infusion Related Reaction, Blood Pressure Decreased
This infusion related reaction side effect was reported by a pharmacist from UNITED STATES. A 75-year-old male patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Sucralfate (dosage: NA), which was started on Apr 24, 2012. Concurrently used drugs:
  • Propofol
  • Aspirin
  • Polyethlene Glycol
  • Percocet
  • Regular Insulin
  • Simvastatin
  • Metformin Hcl
  • Albuminar-25 (25g X 1 Iv)
.When starting to take Sucralfate the consumer reported symptoms, such as:
  • Infusion Related Reaction
  • Blood Pressure Decreased
These side effects may potentially be related to Sucralfate.

Dyspnoea, Chills, Fatigue, Intestinal Perforation, Asthenia, Faeces Discoloured, Haemorrhage, Blood Test Abnormal, Blood Pressure Decreased
This is a report of a 60-year-old male patient (weight: NA) from UNITED STATES, suffering from the following symptoms/conditions: NA, who was treated with Sucralfate (dosage: NA, start time: NS), combined with:
  • Pantoprazole
  • Excedrin (migraine) (1 Df, Qd)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Dyspnoea
  • Chills
  • Fatigue
  • Intestinal Perforation
  • Asthenia
  • Faeces Discoloured
  • Haemorrhage
  • Blood Test Abnormal
  • Blood Pressure Decreased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Sucralfate treatment in male patients, resulting in dyspnoea side effect. The patient was hospitalized.

Glycosylated Haemoglobin Increased, Pancreatic Enzymes Increased, Blood Elastase Increased, Abdominal Pain Upper, Lipase Increased
This report suggests a potential Sucralfate Glycosylated Haemoglobin Increased, Pancreatic Enzymes Increased, Blood Elastase Increased, Abdominal Pain Upper, Lipase Increased side effect(s) that can have serious consequences. A 64-year-old male patient (weight: NA) from JAPAN was diagnosed with the following symptoms/conditions: NA and used Sucralfate (dosage: NA) starting Jan 01, 2011. Soon after starting Sucralfate the patient began experiencing various side effects, including:
  • Glycosylated Haemoglobin Increased
  • Pancreatic Enzymes Increased
  • Blood Elastase Increased
  • Abdominal Pain Upper
  • Lipase Increased
Drugs used concurrently:
  • Bio Three
  • Rabeprazole Sodium
  • Foipan
  • Januvia
  • Berizym (aspergillus Oryzae Extract (+) Cellulase (+) Lipase (+) Pancr
The patient was hospitalized. Although Sucralfate demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as glycosylated haemoglobin increased, may still occur.

Osteonecrosis Of Jaw
This Osteonecrosis Of Jaw problem was reported by a health professional from AUSTRIA. A 67-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On Jan 26, 2012 this consumer started treatment with Sucralfate (dosage: 1 Df, Tid). The following drugs were being taken at the same time:
  • Proton Pump Inhibitors (40 Mg, 1-0-0)
  • Pyridoxine Hydrochloride (1 Df, Bid)
  • Exforge (1 Df, Qd)
  • Thiamine Disulfide (1 Df, Bid)
  • Arimidex (1 Df, Qd)
  • Pantoprazole
  • Cyanocobalamin (1 Df, Bid)
  • Diabetex (100 Mg- 0- 850 Mg)
When commencing Sucralfate, the patient experienced the following unwanted symptoms/side effects:
  • Osteonecrosis Of Jaw
The patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as osteonecrosis of jaw, may become evident only after a product is in use by the general population.

Oesophageal Disorder, Feeling Abnormal, Oesophageal Ulcer, Dysphagia
This is a report of a 57-year-old female patient (weight: NA) from UNITED STATES. The patient developed the following symptoms/conditions: NA and was treated with Sucralfate (dosage: NA) starting Apr 01, 2010. Concurrently used drugs:
  • Nasonex
  • Methylphenidate
  • Oxycontin
  • Nexium
  • Cymbalta
  • Ramipril
  • Omeprazole
  • Metoprolol Tartrate
Soon after that, the consumer experienced the following side effects:
  • Oesophageal Disorder
  • Feeling Abnormal
  • Oesophageal Ulcer
  • Dysphagia
This opens a possibility that Sucralfate treatment could cause the above reactions, including oesophageal disorder, and some female subjects may be more susceptible.

Dyspnoea, Abdominal Pain Upper, Flushing, Chills, Dyspepsia, Nausea
A 40-year-old female patient (weight: NA) from UNITED STATES with the following symptoms/conditions: gastritis started Sucralfate treatment (dosage: NA) on Mar 29, 2012. Soon after starting Sucralfate treatment, the subject experienced various side effects, including:
  • Dyspnoea
  • Abdominal Pain Upper
  • Flushing
  • Chills
  • Dyspepsia
  • Nausea
Concurrently used drugs: NA. This finding indicates that some female patients could be more vulnerable to Sucralfate.

1 of 6 



Top 10 Sucralfate Side Effects for Women

Women Side EffectsReports
Pain 8
Diarrhoea 6
Dyspnoea 6
Pruritus 6
Anxiety 5
Cholecystitis Chronic 5
Cholelithiasis 5
Intra-uterine Death 5
Liver Disorder 5
Nausea 5

Top 10 Sucralfate Side Effects for Men

Men Side EffectsReports
Bezoar 7
Gastrointestinal Haemorrhage 4
Leukocytoclastic Vasculitis 4
Pyrexia 4
Rash 4
Scrotal Oedema 4
Cellulitis 3
Liver Disorder 3
Nausea 3
Pain 3

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Sucralfate Side Effects

    Did You Have a Sucralfate Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Sucralfate for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Sucralfate Safety Alerts, Active Ingredients, Usage Information

    NDC0093-2210
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameSucralfate
    NameSucralfate
    Dosage FormTABLET
    RouteORAL
    On market since19961111
    LabelerTeva Pharmaceuticals USA Inc
    Active Ingredient(s)SUCRALFATE
    Strength(s)1
    Unit(s)g/1
    Pharma ClassAluminum Complex [EPC],Organometallic Compounds [Chemical/Ingredient]

    Sucralfate Dosage, Warnings, Usage.

    Side Effects reported to FDA: 136

    Sucralfate safety alerts: No

    Reported deaths: 19

    Reported hospitalizations: 61

    Latest Sucralfate clinical trials